Infliximab use in patients with Crohn's disease: quality of life, costs and resource use

MeSH terms

• Antibodies, Monoclonal / economics
• Antibodies, Monoclonal / therapeutic use*
• Cohort Studies
• Crohn Disease / drug therapy*
• Crohn Disease / economics
• Crohn Disease / epidemiology
• Drug Costs*
• Europe / epidemiology
• Gastrointestinal Agents / economics
• Gastrointestinal Agents / therapeutic use*
• Health Resources / economics
• Health Resources / statistics & numerical data*
• Humans
• Infliximab
• North America / epidemiology
• Quality of Life*
• Randomized Controlled Trials as Topic